Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioident Technologies was a life sciences company that developed highly sensitive, portable, and low-cost diagnostic systems based on printed organic electronics. Its core technology, the Photonic Lab-on-a-Chip (PLoC), combined microfluidics with organic photodetectors to enable real-time, multi-parameter testing for medical diagnostics and environmental monitoring. The company's platform was designed to move complex laboratory assays to the point of care, offering a disposable and scalable solution for detecting pathogens and biomarkers. By utilizing organic semiconductors instead of traditional silicon, Bioident achieved significant cost reductions and increased flexibility in sensor design. Bioident was acquired by the international technology group Schott in 2008 to integrate its sensor technology into Schott's diagnostic components business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOIDENT Technologies.